Linzagolix will only be available for patients whose previous medical or surgical treatments have been unsuccessful.

A new daily tablet for endometriosis, called linzagolix (also known as Yselty), has been approved for use on the NHS and is ...

A new at-home pill for endometriosis has been approved for use on the NHS.The once-a-day tablet, called linzagolix but also ...

Clinical trials have shown linzagolix significantly reduces both menstrual pain and non-menstrual pelvic discomfort compared ...

Pfizer and Myovant have begun a late-stage trial of their potential uterine fibroid drug relugolix, as part of a contraceptive combination tablet. The FDA is already reviewing data from two ...

Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with uterine ...

Endometriosis is a painful condition that affects one in 10 women in the UK, and can have a big impact on women's lives. The ...

Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

The pill, known as relugolix–estradiol–norethisterone (or relugolix combination therapy, branded as Ryeqo), is considered a breakthrough for the 1.5 million people in the UK living with ...

Relugolix–estradiol–norethisterone (relugolix combination therapy [CT]) can be used, within its marketing authorisation, as an option for treating symptoms of endometriosis in adults of reproductive ...